Protek Group of Companies has been the only actor in the pharmaceutical market, to be included in the TOP 50 of RBC 500 rating. The holding has become 48-th in the list of the leading enterprises, which is one point higher, compared to the 2017 rating.
The RBC 500 rating-2018 included 28 companies representing the pharmaceutical industry. The TOP-3 distributors which established a lead are: Katren company going in path of Protek Group of Companies, took 52nd position, and Pulse FC – the 88th. By a significant margin after came Pharmstandart (173rd position) and R-Pharm (201st position).
"We got one more point in the current RBC rating, which testifies to the company's financial stability and prospects of the strategy we pursue," – Vadim Muzyaev, President of Protek Group of Companies, commented.